|
Hematology Oncology Grand 2022 |
12/28/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
12/21/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
12/14/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
12/07/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
11/30/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
11/23/2022 - 8:00am to 9:00am EST |
|
Tackling resistance in triple negative breast cancer |
11/16/2022 - 8:00am to 9:00am EST |
|
Complement Activation in HIT |
11/09/2022 - 8:00am to 9:00am EST |
|
Optimal Duration of Therapy in Metastatic RCC: Exploring Treatment Free Survival with Immune Checkpoint Inhibitors and Let's talk about the elephant in the room: Hemophagocytic Lymphohistocytosis (HLH) |
11/02/2022 - 8:00am to 9:00am EDT |
|
A Multi-Level Model to Address Cervical Cancer Disparities in Appalachia |
10/26/2022 - 8:00am to 9:00am EDT |
Facebook
Twitter
LinkedIn
Forward